Golden age of domestic biopharmaceutical products, pouring foreign entries

At the beginning of the year, foreign expansion of domestic biopharmaceutical products has produced results. While technology of the anemia treatment being developed by Chong Kun Dang is exported, Samsung Bioepis acquired European approval to sell its Enbrel biosimilar.

On the 17^th, Samsung Bioepis announced ‘Benepali,’ a biosimilar of ‘Enbrel,’ an autoimmune disease treatment, was approved by...